Biosino Bio-Technology & Science, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000288
HKD
2.10
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Biosino Bio-Technology & Science, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-64.00
-33.00
13.00
5.00
0.00
-135.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
36.00
-3.00
2.00
-6.00
-6.00
-17.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
18.00
-13.00
44.00
46.00
13.00
33.00
Cash Flow from Investing Activities
-14.00
-1.00
-1.00
-7.00
-29.00
43.00
Cash Flow from Financing Activities
1.00
0.00
-5.00
-40.00
34.00
-63.00
Net Cash Inflow / Outflow
5.00
-15.00
38.00
-1.00
17.00
13.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biosino Bio-Technology & Science, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-64.2988107558804
23.885
-87.00
-369.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
36.306319590102
-60.463
96.00
160.05%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
18.2485714931914
-32.318
50.00
156.47%
Cash Flow from Investing Activities
-14.9677101457731
0
-14.00
0.00%
Cash Flow from Financing Activities
1.98196118409803
17.386
-16.00
-88.60%
Net Cash Inflow / Outflow
5.20752711554859
-17.313
22.00
130.08%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0552954159677239
-2.381
2.00
97.68%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 238.14% vs -129.59% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
18.25
-13.21
238.14%